Dorval Allison
Insider CIK 1625110 · PODD Chief Financial Officer · PBYI Director · VYGR Chief Financial Officer · AVTE Director · VERV Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PBYI PUMA BIOTECHNOLOGY, INC. | S Sale | 2026-06-12 | 2026-06-15 | 11,610 | $7.20 | $83.6K | 90,780 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award | 2026-06-11 | 2026-06-15 | 27,000 | — | $0 | 102,390 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 180,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 33,750 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 258,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 1,875 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 45,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 75,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | U Tender | 2025-07-25 | 2025-07-28 | 13,280 | — | $0 | 0 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | S Sale | 2025-06-13 | 2025-06-17 | 11,610 | $3.40 | $39.5K | 75,390 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award | 2025-06-11 | 2025-06-13 | 27,000 | — | $0 | 87,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2025-04-02 | 2025-04-03 | 3,350 | $4.15 | $13.9K | 13,280 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2025-04-01 | 2025-04-03 | 11,250 | — | $0 | 33,750 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2025-04-01 | 2025-04-03 | 11,250 | — | $0 | 16,630 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-01-08 | 2025-01-10 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-01-08 | 2025-01-10 | 258,000 | — | $0 | 258,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-01-08 | 2025-01-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2024-12-02 | 2024-12-03 | 555 | $5.64 | $3.1K | 5,380 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2024-11-29 | 2024-12-03 | 1,875 | — | $0 | 1,875 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2024-11-29 | 2024-12-03 | 1,875 | — | $0 | 5,935 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award | 2024-06-18 | 2024-06-21 | 27,000 | — | $0 | 60,000 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | S Sale | 2024-06-13 | 2024-06-17 | 11,000 | $3.37 | $37.1K | 33,000 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 180,000 | — | $0 | 180,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2023-11-29 | 2023-12-01 | 1,875 | — | $0 | 3,750 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2023-11-29 | 2023-12-01 | 554 | $11.45 | $6.3K | 4,060 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2023-11-29 | 2023-12-01 | 1,875 | — | $0 | 4,614 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award | 2023-06-13 | 2023-06-15 | 27,000 | — | $0 | 44,000 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | S Sale | 2023-06-13 | 2023-06-15 | 10,000 | $3.45 | $34.5K | 17,000 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2023-06-06 | 2023-06-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2023-02-14 | 2023-02-16 | 182,800 | — | $0 | 182,800 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2022-11-29 | 2022-12-01 | 1,875 | — | $0 | 5,625 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2022-11-29 | 2022-12-01 | 1,875 | — | $0 | 2,740 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-29 | 2022-12-01 | 554 | $22.10 | $12.2K | 2,186 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2022-06-21 | 2022-06-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award | 2022-06-14 | 2022-06-17 | 27,000 | — | $0 | 27,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2022-02-11 | 2022-02-15 | 60,000 | — | $0 | 60,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2021-11-29 | 2021-11-30 | 7,500 | — | $0 | 7,500 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2021-11-29 | 2021-11-30 | 135,000 | — | $0 | 135,000 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award deriv | 2021-07-15 | 2021-07-16 | 108,721 | — | $0 | 108,721 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2021-07-15 | 2021-07-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award | 2021-03-19 | 2021-03-23 | 30,000 | — | $0 | 109,894 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2021-02-16 | 2021-02-18 | 68,000 | — | $0 | 68,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award | 2021-02-16 | 2021-02-18 | 34,000 | — | $0 | 79,894 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2021-02-11 | 2021-02-16 | 3,186 | $7.55 | $24.1K | 45,894 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2021-01-12 | 2021-01-14 | 2,942 | $8.62 | $25.4K | 49,080 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2020-02-10 | 2020-02-12 | 55,000 | — | $0 | 55,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award | 2020-02-10 | 2020-02-12 | 27,500 | — | $0 | 52,022 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2020-01-21 | 2020-01-29 | 3,128 | $13.36 | $41.8K | 24,522 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2019-01-11 | 2019-01-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award | 2019-01-11 | 2019-01-17 | 25,000 | — | $0 | 26,106 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2018-11-07 | 2018-11-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| PODD INSULET CORP | F Tax w/h | 2015-04-01 | 2015-04-03 | 814 | $31.85 | $25.9K | 37,415 | SEC↗ |
| PODD INSULET CORP | F Tax w/h | 2015-03-03 | 2015-03-04 | 851 | $31.37 | $26.7K | 38,229 | SEC↗ |
| PODD INSULET CORP | A Award deriv | 2015-03-02 | 2015-03-04 | 14,607 | — | $0 | 14,607 | SEC↗ |
| PODD INSULET CORP | A Award | 2015-03-02 | 2015-03-04 | 10,253 | — | $0 | 39,080 | SEC↗ |
| PODD INSULET CORP | F Tax w/h | 2015-03-01 | 2015-03-03 | 1,091 | $31.73 | $34.6K | 28,827 | SEC↗ |
| PODD INSULET CORP | A Award deriv | 2014-12-01 | 2014-12-03 | 11,148 | — | $0 | 11,148 | SEC↗ |
| PODD INSULET CORP | A Award | 2014-12-01 | 2014-12-03 | 7,576 | — | $0 | 29,918 | SEC↗ |